Drug Retail(BK4128),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4128 Drug Retail

Market Closed 05-15 16:00:00 EDT

42.25

-3.10

-6.84%

High45.80	Low42.13	Vol46.11M
Open45.80	D1 Closing45.36	Amplitude8.08%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O6.38M	T/O Rate--	Tradable Shares0.00
P/B-1.634305	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4128","market":"US","secType":"PLATE","nameCN":"Drug Retail","latestPrice":42.254513,"timestamp":1778875199999,"preClose":45.3584,"halted":0,"volume":46113909,"delay":0,"changeRate":-0.06843,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-3.103886,"latestTime":"05-15 16:00:00 EDT","open":45.7982,"high":45.7982,"low":42.13425,"amount":6378310.598193,"amplitude":0.080778,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":-1.634305,"peRate":-1.665788,"turnoverRate":0.084921,"increases":1,"decrements":3,"flats":0,"marketCap":128490293,"floatMarketCap":97799159.125},"requestUrl":"/m/hq/s/BK4128/wiki","defaultTab":"wiki","newsList":[{"id":"2635058893","title":"Mangoceuticals delays Q1 10-Q filing as auditor review takes longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058893","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058893?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:46","pubTimestamp":1778877965,"startTime":"0","endTime":"0","summary":"Mangoceuticals filed a Form 12b-25 to delay its Form 10-Q for quarter ended March 31, 2026.Filing missed prescribed deadline as auditor required more time to complete review.Company expects to file report within 5 calendar days of original due date.Notice flagged no anticipated significant change in results of operations versus prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL7KKvBG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","MGRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635847210","title":"Press Release: SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2635847210","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635847210?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:30","pubTimestamp":1778848200,"startTime":"0","endTime":"0","summary":"NORTH PALM BEACH, Fla., May 15, 2026  -- SRx Health Solutions, Inc.   and EMJ Crypto Technologies , a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced board approval to dividend 75% of profits from investment in Astro Investment XVII, an affiliate of Astro Capital and special purpose vehicle , with investments in SpaceX and other artificial intelligence and space companies.The Company recently announced an investment of greater than 10% of its investable capital in Astro Investment XVII and will return capital to shareholders upon wind down of the SPV.\"This investment demonstrates our belief in the long-term value of both AI and space,\" said Michael Young, Board Member of SRx Health. \"Our investment in EMJX and Astro Capital provides an avenue to invest in these high potential growth areas through technology and professional managers. With board approval to issue a dividend upon wind down the SPV and profit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UFO","IPO001","BK4128","BK4212","SRXH","XOVR","DXYZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729127","title":"SRX HealthSolutions Q2 EPS $(0.02) Up From $(0.39) YoY, Sales $3.439M","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729127","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729127?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:09","pubTimestamp":1778792945,"startTime":"0","endTime":"0","summary":"SRX HealthSolutions (AMEX:SRXH) reported quarterly losses of $(0.02) per share. This is a 94.87 percent increase over losses of $(0.39) per share from the same period last year.  The company reported $3.439 million in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52583919/srx-healthsolutions-q2-eps-0-02-up-from-0-39-yoy-sales-3-439m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"SRX HealthSolutions Q2 EPS $(0.02) Up From $(0.39) YoY, Sales $3.439M","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRXH","BK4212","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635872504","title":"SRX Health Solutions Q2 revenue rises, EBITDA loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2635872504","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635872504?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:32","pubTimestamp":1778790764,"startTime":"0","endTime":"0","summary":"SRX Health Solutions Q2 revenue rises, EBITDA loss narrowsOverviewUS pet health and wellness firm's fiscal Q2 revenue rose 23% sequentially to $3.4 mlnAdjusted EBITDA loss improved about 44% quarter o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","SRXH","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635237297","title":"SRx Health Q1 net loss narrows to $6.38 million; net sales rise to $3.44 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635237297","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635237297?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:10","pubTimestamp":1778789406,"startTime":"0","endTime":"0","summary":"SRX Health Solutions posted a net loss of USD 6.38 million for quarter ended March 31, 2026, narrowing from USD 10.15 million a year earlier.Net sales were USD 3.44 million, gross margin was 37% with gross profit of USD 1.28 million.Operating loss was USD 1.82 million, while interest expense totaled USD 1.78 million.Business reset continued following SRx Canada CCAA proceedings, with former specialty pharmacy and clinical operations wound down and focus shifted to Halo-branded pet food and wellness products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Health Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDLQLPYq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","SRXH","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635972809","title":"Srx Health Solutions Inc Q2 Gross Margin 37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635972809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635972809?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789104,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX8F1DFC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRXH","BK4128","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635238717","title":"Srx Health Solutions Inc Q2 Operating Income USD -1.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635238717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635238717?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789104,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX8F1DFC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRXH","BK4212","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723351","title":"Srx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723351","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723351?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA83P1QH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4212","SRXH","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635914723","title":"Press Release: SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635914723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635914723?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789100,"startTime":"0","endTime":"0","summary":"Q2 FY26 Marks Operational Inflection Point with Sequential 23% Revenue Growth and 44% Adjusted EBITDA Loss Improvement. Strengthened Liquidity and Working Capital Position with Cash of $20.5 million as of Quarter End. Active Cryptocurrency Strategy Outperformed Market by 6%, Reducing Losses by 23% Relative to Buy-and-Hold. NORTH PALM BEACH, Fla., May 14, 2026  -- SRx Health Solutions, Inc.  , a pet health and wellness company, today announced its financial results for the fiscal second quarter 2026.On or about May 15, 2026, the Company intends to mail an information statement to shareholders in connection with its previously announced pending acquisition of EMJ Crypto Technologies Inc. . The information statement is part of the Registration Statement on Form S-4 that was filed by the Company with the Securities and Exchange Commission and can be obtained free of charge on the SEC's website at www.sec.gov or the Company's website at srxhealth.com. The acquisition remains subject to cert","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4128","R","BK4212","SRXH","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782954","title":"SRx Health invests over 10% of investable capital in Astro Investment XVII SPV","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782954","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782954?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:33","pubTimestamp":1778675582,"startTime":"0","endTime":"0","summary":"SRx Health Solutions invested more than 10% of its investable capital in Astro Investment XVII, an Astro Capital-affiliated SPV with holdings that include SpaceX.Transaction positions SRx Health for indirect exposure to artificial intelligence and space-focused investments through Astro Capital-managed vehicle.Disclosure comes alongside SRx Health merger agreement with EMJ Crypto Technologies, described as digital-asset treasury operating platform.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL5xZ77G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4588","SG9999014005.SGD","NDAQ","SRXH","BK4585","BK4128","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4212","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014021.USD","BK4009","BK4112","IE00B64PRP62.GBP","QXL","LU2210150020.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635825977","title":"Srx Health Solutions Invests in Astro Investment Xvii, an Affiliate of Astro Capital and Spv With Investments in Spacex and Other Artificial Intelligence and Space Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2635825977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635825977?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:30","pubTimestamp":1778675400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA2JDH1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SRXH","BK4212","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635287227","title":"Radius Residential Care Sees Continued Underlying Growth In Key Financial Metrics In FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2635287227","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635287227?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:48","pubTimestamp":1778636887,"startTime":"0","endTime":"0","summary":"May 13 (Reuters) - Radius Residential Care Ltd ::*EXPECTS CONTINUED UNDERLYING GROWTH IN KEY FINANCIAL METRICS IN FY27*FY ADJUSTED EBITDA NZD 27.4 MILLION*FY NET INCOME NZD 9.5 MILLION*FINAL CASH DIVI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nRSD9ZdD68:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","RAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635229959","title":"BUZZ-New Zealand's Radius Residential Care rises on upbeat annual results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635229959","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635229959?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:26","pubTimestamp":1778628380,"startTime":"0","endTime":"0","summary":"BUZZ-New Zealand's Radius Residential Care rises on upbeat annual results** Shares of Radius Residential Care RAD.NZ rise as much as 2.6% to NZ$0.400, hitting their highest level since April 30** Aged care services provider reports FY net profit after tax of NZ$9.5 million , up 34% from a year earlier** Co announces final dividend of 1.2 NZ cents per share, up 50% from a year earlier** Adds it expects continued underlying growth in key financial metrics in FY27** Stock up over 2.5% this year, including session's move  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL4N41P2DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240202","title":"Radius Residential Care Ltd - ‍Final Cash Dividend of 1.2 Nz Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240202?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:31","pubTimestamp":1778617870,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLX28A327:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAD","BK4128"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240215","title":"Radius Residential Care - Expects Continued Underlying Growth in Key Financial Metrics in FY27","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240215?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:30","pubTimestamp":1778617832,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1I1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","RAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240294","title":"Radius Residential Care FY Net Income Nzd 9.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240294","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240294?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:30","pubTimestamp":1778617813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLXA793C5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","RAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635244470","title":"Guardian Pharmacy Services names eight new senior vice presidents in leadership reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2635244470","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635244470?lang=en_us&edition=fundamental","pubTime":"2026-05-13 03:03","pubTimestamp":1778612602,"startTime":"0","endTime":"0","summary":"Guardian Pharmacy Services promoted six corporate leaders to senior vice president roles to tighten operational alignment across its national pharmacy network.Appointments include Will Mudd, CPA, as SVP of Finance; Doug Towns as SVP, General Counsel and Senior Compliance Officer; David Martin as SVP of Technology, Data and Senior Security Officer.Regional leadership expanded with multiple tenured pharmacy presidents elevated to SVP posts, including David Brown to lead Central Region, John Saliba to lead West Region, Khristy McClelland to lead Southeast Region.Several pharmacy presidents moved into regional pharmacy president roles, including Ron Belville for California, Matt Hopp for Georgia, Tom Mullaney for Ohio.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL4kJgfz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRDN","BK4128","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634624364","title":"Guardian Pharmacy promotes Jeff Kerr to president of Sauk Rapids pharmacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2634624364","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634624364?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:16","pubTimestamp":1778598994,"startTime":"0","endTime":"0","summary":"Guardian Pharmacy Services promoted Jeff Kerr to president of Guardian Pharmacy of Minnesota’s Sauk Rapids pharmacy.Kerr will oversee daily operations, focus on customer relationships, drive growth.He succeeds Mark Boe, retiring after 14 years leading Sauk Rapids operation.Kerr joined Sauk Rapids pharmacy in 2015, credited with supporting sustainable growth, operational efficiency, long-term financial strength over past decade.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardian Pharmacy Services Inc. published the original content used to generate this news brief on May 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDLb3qP6J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","BK4196","GRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634237262","title":"HealthWarehouse.com Q1 sales fall after FDA ends GLP-1 shortage","url":"https://stock-news.laohu8.com/highlight/detail?id=2634237262","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634237262?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:19","pubTimestamp":1778530796,"startTime":"0","endTime":"0","summary":"HealthWarehouse.com Q1 sales fall after FDA ends GLP-1 shortageOverviewU.S. healthcare e-commerce platform's Q1 net sales fell 58% after FDA ended GLP-1 shortageCompany posted Q1 net loss and negative","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL1N41O0ZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","BK4122","HEWA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634774232","title":"HealthWarehouse Q1 FY26 turns to $361,000 net loss; net sales drop 57.8% to $6.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634774232","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634774232?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:08","pubTimestamp":1778530110,"startTime":"0","endTime":"0","summary":"Net results swung to a loss of $361,000 from profit, with operating results turning to a $312,000 loss.Gross profit fell 27.3% to $3.3 million, while gross margin rose 21.9 percentage points to 52.1%.Partner services  prescription sales dropped $8.8 million, while over-the-counter net sales climbed 61.9% to $934,000.Management pointed to new business units and strategic partnerships to help fill the gap, highlighting a recently announced partnership with healthwords.ai alongside continued investment in proprietary technology to improve customer experience, efficiency, and scalability.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL4yQ8Yf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","HEWA","BK4122"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4128","nameEN":"BK4128"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Drug Retail(BK4128),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Drug Retail(BK4128) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Drug Retail,BK4128,Drug Retail股票,Drug Retail股票老虎,Drug Retail股票老虎国际,Drug Retail行情,Drug Retail股票行情,Drug Retail股价,Drug Retail股市,Drug Retail股票价格,Drug Retail股票交易,Drug Retail股票购买,Drug Retail股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Drug Retail(BK4128),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Drug Retail(BK4128) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction